NEW LEAF VENTURES III, L.P. – $375 MILLION LIMITED PARTNER INTERESTS – CONFIDENTIAL PRIVATE PLACEMENT MEMORANDUM APRIL, 2014 Control No. 257 NEW LEAF VENTURES III, L.P. – $375 MILLION LIMITED PARTNER INTERESTS – CONFIDENTIAL PRIVATE PLACEMENT MEMORANDUM APRIL, 2014 NEW LEAF VENT...
Results for “Nissan Leaf”
Search across the indexed text of every released document.
Names that match “Nissan Leaf”
76 documents found
I. EXECUTIVE SUMMARY FUND OVERVIEW New Leaf Ventures III, L.P. (““NLV-II” or the “Fund”) is being formed by New Leaf Venture Partners, L.L.C. (“New Leaf” or the “Management Company”), an established and proven leader in health care technology investing. NLV-III will be the seve...
Il. THE TEAM NLV-III will be managed by the New Leaf team, which currently manages NLV-I, NLV-IL, and provides sub-advisory services managing the remaining healthcare technology investments in the Sprout Funds. The team of six senior partners, five of whom have worked together c...
Explaining our taste for excessive harm Marc D. Hauser Viking/Penguin For Jacques and Bert Hauser, my parents, my friends, and my reminder that life should be lived to its fullest Hauser Evilicious. Front matter 2 Pleasure is the greatest incentive to evil. ⎯⎯ Plato To witness s...
MEDICAL DEVICES RETURNS SUMMARY: The Fund Managers have been an active investor in the medical device sector across the New Leaf and Sprout Funds. Combined, the Fund Managers have invested $371 million in 29 medical device companies, and have gross realizations of $394 million a...
OTHER INVESTMENT PROFESSIONALS Kathy LaPorte, (52), Venture Partner, is an angel investor in the Digital Health space focusing on evaluating and mentoring start-ups developing digital technology solutions for healthcare consumers, providers, payers and the pharmaceutical/medical...
000 that was set by the Department of Energy. Sales of the Nissan Leaf in the US are down 28% vs 2011.
Leadership: NLV_ are leaders in biopharmaceutical investing across all stages and transaction types The New Leaf team is well positioned to continue to play a leadership role in the sector. Over the last two decades, the Fund Managers have demonstrated an ability to access high...
TOWN OF PALM BEACH POLICE DEPARTMENT A NATIONAL AND STATE ACCREDITED LAW ENFORCEMENT AGENCY CODE ENFORCEMENT BOARD MINUTES 2:00 P.M. THURSDAY, JULY 17, 2008...
The New Leaf team applies a rigorous, systematic, fundamentals-driven approach to diligence on all new deals, which, in addition to assessment against the sector specific strategies, includes consideration of the following risk/ reward factors: e Medical need and market size e...
molecular immunology at The Pasteur Institute and earned an M.D. and Ph.D. from the University of Paris, and an M.B.A. from Columbia University. Jeani Delagardelle, (57), Managing Director, helped found New Leaf in 2005. She joined Sprout in 2000. At New Leaf, Jeani leads the Me...
Code Enforcement Board Meeting Minutes 07/17/08 Violation of Chapter 42, Section 42-86 (19) of the Town of Palm Beach Code of Ordinances, cleared land must be re-sodded or replanted to prevent the creation of windblown dust or dirt and Chapter 42, Section 42-86, unsightly, unsaf...
number of commercial stage companies with novel and clearly differentiated products targeting defined and established high growth market segments. DEAL FLOW AND INVESTMENT PROCESS The Fund Managers have a proactive approach to deal sourcing, which targets both private and publi...
Appendix 2 All Funds Gross and Net Returns $ amounts in millions, as of March 31, 2014 Total Cost Realized Unrealized Realized Overall Realized Overall New Leaf Ventures II, L.P. (2008) New Leaf Ventures I, L.P. (2005) Sprout Capital IX, L.P. (2000) (Healthcare Technology) S...
…laintiffs must allege sufficient facts to warrant jurisdictional discovery. Robinson, 269 F.3d at 146 (citing Jazini v. Nissan Motor Co., 148 F.3d 181, 185 (2d Cir.1998) (refusing jurisdictional discovery where plaintiffs’ allegations lacked factual specificity to confer jurisdic...